Bellevue Group’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-247,886
| Closed | -$16.7M | – | 182 |
|
|
2025
Q3 | $16.7M | Hold |
247,886
| – | – | 0.35% | 49 |
|
|
2025
Q2 | $16.2M | Hold |
247,886
| – | – | 0.36% | 53 |
|
|
2025
Q1 | $15.3M | Hold |
247,886
| – | – | 0.34% | 61 |
|
|
2024
Q4 | $17.9M | Buy |
247,886
+22
| +0% | +$1.72K | 0.34% | 66 |
|
|
2024
Q3 | $20.2M | Buy |
247,864
+38
| +0% | +$3.04K | 0.33% | 71 |
|
|
2024
Q2 | $18.4M | Sell |
247,826
-42,143
| -15% | -$3.16M | 0.3% | 77 |
|
|
2024
Q1 | $22.6M | Buy |
289,969
+105
| +0% | +$7.81K | 0.34% | 75 |
|
|
2023
Q4 | $20.7M | Sell |
289,864
-272
| -0.1% | -$18.9K | 0.32% | 73 |
|
|
2023
Q3 | $20.1M | Hold |
290,136
| – | – | 0.32% | 74 |
|
|
2023
Q2 | $23.5M | Hold |
290,136
| – | – | 0.34% | 68 |
|
|
2023
Q1 | $23.4M | Buy |
290,136
+46,965
| +19% | +$3.78M | 0.34% | 74 |
|
|
2022
Q4 | $18.2M | Sell |
243,171
-8,241
| -3% | -$587K | 0.24% | 88 |
|
|
2022
Q3 | $16.2M | Sell |
251,412
-19,413
| -7% | -$1.34M | 0.23% | 91 |
|
|
2022
Q2 | $18.8M | Sell |
270,825
-4,958
| -2% | -$368K | 0.27% | 88 |
|
|
2022
Q1 | $21.2M | Sell |
275,783
-303,641
| -52% | -$21.8M | 0.25% | 91 |
|
|
2021
Q4 | $44.4M | Sell |
579,424
-291,238
| -33% | -$21.4M | 0.46% | 68 |
|
|
2021
Q3 | $64.3M | Sell |
870,662
-43,090
| -5% | -$3.23M | 0.65% | 50 |
|
|
2021
Q2 | $61M | Hold |
913,752
| – | – | 0.6% | 56 |
|
|
2021
Q1 | $68M | Buy |
913,752
+5,164
| +0.6% | +$392K | 0.72% | 48 |
|
|
2020
Q4 | $66.2M | Buy |
908,588
+211,608
| +30% | +$14.9M | 0.76% | 37 |
|
|
2020
Q3 | $46.3M | Buy |
696,980
+165,891
| +31% | +$10.5M | 0.64% | 46 |
|
|
2020
Q2 | $30.3M | Sell |
531,089
-36,690
| -6% | -$1.8M | 0.43% | 57 |
|
|
2020
Q1 | $19.9M | Buy |
567,779
+306,000
| +117% | +$14.6M | 0.39% | 63 |
|
|
2019
Q4 | $13.7M | Buy |
261,779
+106,571
| +69% | +$5.31M | 0.22% | 77 |
|
|
2019
Q3 | $7.84M | Buy |
155,208
+7,660
| +5% | +$377K | 0.15% | 94 |
|
|
2019
Q2 | $7.08M | Buy |
147,548
+57,548
| +64% | +$2.66M | 0.12% | 97 |
|
|
2019
Q1 | $4.36M | Hold |
90,000
| – | – | 0.24% | 80 |
|
|
2018
Q4 | $3.7M | Sell |
90,000
-271,894
| -75% | -$11.2M | 0.24% | 81 |
|
|
2018
Q3 | $14.8M | Hold |
361,894
| – | – | 0.94% | 37 |
|
|
2018
Q2 | $14.4M | Sell |
361,894
-122,000
| -25% | -$4.69M | 1.23% | 28 |
|
|
2018
Q1 | $18.1M | Hold |
483,894
| – | – | 1.79% | 19 |
|
|
2017
Q4 | $20.7M | Buy |
483,894
+120,793
| +33% | +$4.82M | 2.16% | 12 |
|
|
2017
Q3 | $13.3M | Buy |
363,101
+89,678
| +33% | +$3.62M | 1.39% | 25 |
|
|
2017
Q2 | $12.4M | Sell |
273,423
-69,067
| -20% | -$3.05M | 1.47% | 21 |
|
|
2017
Q1 | $14.6M | Buy |
342,490
+122,890
| +56% | +$5.01M | 1.94% | 16 |
|
|
2016
Q4 | $8.81M | Sell |
219,600
-22,500
| -9% | -$868K | 1.8% | 19 |
|
|
2016
Q3 | $9.4M | Buy |
242,100
+3,800
| +2% | +$143K | 1.7% | 18 |
|
|
2016
Q2 | $8.24M | Buy |
238,300
+157,300
| +194% | +$5.45M | 1.55% | 20 |
|
|
2016
Q1 | $2.79M | Buy |
+81,000
| New | +$2.82M | 0.51% | 68 |
|
Other funds holding HOLX
HI
PCM
Bellevue Group's HOLX Position: Q4 2025 in Review
Bellevue Group sold out of Hologic (HOLX) in Q4 2025, closing a stake of 247,886 shares — an estimated $16.7M sold.
Bellevue Group first reported a position in HOLX in Q1 2016 and held it in 39 quarters. The position peaked at $68M in Q1 2021. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.
- Bellevue Group reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
- Bellevue Group sold 247,886 Hologic shares in Q4 2025, an estimated $16.7M.
- Bellevue Group first reported a position in Hologic in Q1 2016 and held it in 39 quarters.
- Bellevue Group's Hologic position peaked at $68M in Q1 2021.
- 749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.
Based on Bellevue Group's 13F filing for Q4 2025, filed 17 Feb 2026.